The University of Chicago Header Logo

Editorial perspective. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?

Editorial perspective. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial? Am J Nephrol. 2010; 31(5):469-70.

View in: PubMed